Aztherapies

Small molecule drugs and drug delivery systems for Alzheimer's disease.

placeBoston, Massachusetts, United States calendar_todayFounded 2011 groups10 employees language aztherapies.com

Registered entities

Innovation

12 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,057 times.

YearFilings
20151
20161
20173
20184
20195
20205
20216
20226
20233
20241
20252

Investor mix

16 investors on record; lead investors include The Cosine Group, Spinnaker Capital Group, Duopharma Biotech Berhad.

Investor typeCountShare
Venture capital1063%
Private equity16%
Bank & private debt213%
Other / undisclosed319%
Coming soon